BostonGene Announces the Launch of its CLIA-certified and CAP-accredited Liquid Biopsy, Immunoprofiling and Spatial Proteomics Solutions
Expanding Portfolio of Tests Accelerates the Development of Novel Assays, Analytical Tools and Pipelines to…
Expanding Portfolio of Tests Accelerates the Development of Novel Assays, Analytical Tools and Pipelines to…
NEW YORK, June 02, 2023 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation…
NEW YORK, June 02, 2023 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation…
Company recognized for superior threat detection in its mission to protect SMBs ELLICOTT CITY, Md.,…
Company recognized for superior threat detection in its mission to protect SMBs ELLICOTT CITY, Md.,…
LAS VEGAS, NV, Jun 2, 2023 – (ACN Newswire) – The AC200P power station, made…
LAS VEGAS, NV, Jun 2, 2023 – (ACN Newswire) – The AC200P power station, made…
SYDNEY, AU, Jun 2, 2023 – (ACN Newswire) – Vivid Sydney has enjoyed its largest-ever…
SYDNEY, AU, Jun 2, 2023 – (ACN Newswire) – Vivid Sydney has enjoyed its largest-ever…
Kathmandu, Jun 2, 2023 – (ACN Newswire) – Fonepay, Nepal’s Largest Payment Network announced a…
The partnership between two market leaders provides seamless integration with the ability to create targeting…
FAIRFIELD, N.J.–(BUSINESS WIRE)–DLA, LLC (DLA), a leading provider of internal audit and accounting advisory services,…
BUFFALO, N.Y.–(BUSINESS WIRE)–Columbus McKinnon Corporation (Nasdaq: CMCO), a leading designer, manufacturer and marketer of intelligent…
The first user of the Ultimate AI TechLuxury FF 91 vehicle has signed the first…
Wildwood at Laurel Ranch offers personalized, new homes close to desirable schools and outdoor recreation,…
BOSTON, June 02, 2023 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
BOSTON, June 02, 2023 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
Topline results using the Company’s SCI-110 met the trial’s primary and secondary end points, demonstrating…
Topline results using the Company’s SCI-110 met the trial’s primary and secondary end points, demonstrating…
CALGARY, Alberta, June 02, 2023 (GLOBE NEWSWIRE) — Providence Therapeutics Holdings Inc. (“Providence”), a biopharmaceutical…